Ikaris Pharma Private Limited
About Ikaris Pharma Private Limited
Data last updated:
Ikaris Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 29 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2021PTC372413. Its GSTIN is 27AAGCI4301K1ZN (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Nikhil Ramnath Chourawar and Sonal Vinodrao Munishwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 73 Kolbaswami Soc Vidya Nagar Katol Road, Nagpur, Maharashtra, India – 440013.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.17 Lakh, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹2.49 Lakh (net margin 5.3%) and EBITDA of ₹4.37 Lakh (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 371% over three years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Company details
Contact details
Ikaris Pharma Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 73 Kolbaswami Soc Vidya Nagar Katol Road, Nagpur, Maharashtra, India – 440013
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Ikaris Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ikaris Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Ikaris Pharma Private Limited, buy the company report.
Financials of Ikaris Pharma Private Limited
FY 2025 filings availableIkaris Pharma Private Limited reported revenue of ₹47.17 Lakh (up 75% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 371% over three years, including 75% growth in the latest year. EBITDA rose 229% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹4.37 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.49 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.3% | |||
| Net Profit Margin | 5.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ikaris Pharma Private Limited, buy the company report.
Board of directors of Ikaris Pharma Private Limited
Ikaris Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Ramnath Chourawar | Director | 29 Nov 2021 | 4 Years 11 Months | Current |
| Sonal Vinodrao Munishwar | Director | 29 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Ikaris Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Partine India Private Limited | ₹47.52 Lakh (FY 2025) | 20.0% | New Delhi, Delhi, India | |||
| Bo Tree Ayurveda Private Limited | ₹47.52 Lakh (FY 2025) | 129.0% | Bhopal, Madhya Pradesh, India | |||
| Smileazy Solutions Private Limited | ₹47.51 Lakh (FY 2024) | 997.0% | Gurgaon, Haryana, India | |||
| Babyama Paediatric Centre Private Limited | ₹47.22 Lakh (FY 2025) | 72.0% | Coimbatore, Tamil Nadu, India | |||
| Asha Diagnostics & Research Center Private Limited | ₹47.19 Lakh (FY 2025) | 253.0% | Kolkata, West Bengal, India | |||
| Ikaris Pharma Private Limitedthis company | ₹47.17 Lakh (FY 2025) | ₹2.49 Lakh | 5.3% | 75.0% | Nagpur, Maharashtra, India | |
| Dental Planet Private Limited | ₹47.15 Lakh (FY 2024) | 47050.0% | Delhi, India | |||
| Homely Hands Healthcare Private Limited | ₹47.09 Lakh (FY 2024) | 155.0% | Gurgaon, Haryana, India | |||
| TVM Diagnostics (OPC) Private Limited | ₹47.09 Lakh (FY 2025) | -22.0% | Thiruvananthapuram, Kerala, India | |||
| Siliguri Eye Care Private Limited | ₹46.96 Lakh (FY 2024) | 3.0% | Siliguri, West Bengal, India | |||
| Mohan Medicare Private Limited | ₹46.96 Lakh (FY 2024) | 25.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Ikaris Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2025 | 101189214 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ikaris Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ikaris Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ikaris Pharma Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Ikaris Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCI4301K1ZN | Maharashtra | Active | 10 Dec 2021 |
To see the full GST registrations and return filing status of Ikaris Pharma Private Limited, buy the company report.
Recent activity
Ikaris Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Nikhil Ramnath Chourawar was appointed as Director on 29 Nov 2021.
Frequently asked questions
Ikaris Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 29 November 2021 (5+ years old) and is registered under CIN U24304MH2021PTC372413.
Ikaris Pharma has 2 current directors:
- Nikhil Ramnath Chourawar - Director
- Sonal Vinodrao Munishwar - Director
The latest financial statements of Ikaris Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Ikaris Pharma is 27AAGCI4301K1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ikaris Pharma is U24304MH2021PTC372413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ikaris Pharma was incorporated on 29 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ikaris Pharma by revenue are Partine India Private Limited, Bo Tree Ayurveda Private Limited, Smileazy Solutions Private Limited, Babyama Paediatric Centre Private Limited, Asha Diagnostics & Research Center Private Limited and 5 more, all in the same principal business activity (human health activities).
Nikhil Ramnath Chourawar was appointed as Director on 29 Nov 2021. Sonal Vinodrao Munishwar was appointed as Director on 29 Nov 2021.
The registered office of Ikaris Pharma is at Plot No 73 Kolbaswami Soc Vidya Nagar Katol Road, Nagpur, Maharashtra, India – 440013.
Ikaris Pharma operates in the food and beverages industry, in the artificial fibres segment.
Ikaris Pharma has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
